March 2017 - Page 19 of 49 - NetworkNewsWire

TuesdayMar 14, 2017 3:30 pm

Gentherm, Inc. (NASDAQ: THRM) Starts Presentation at 29th Annual ROTH Conference

Gentherm (NASDAQ: THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include actively heated and cooled seat systems and cup holders, heated and ventilated seat systems, thermal storage bins, heated automotive interior systems, battery thermal management systems, cable systems and other electronic devices. Non-automotive products include remote power generation systems, heated and cooled furniture, patient temperature management systems, industrial environmental test chambers and related product testing services and other consumer and industrial temperature control applications. The company's advanced technology team is developing more efficient…

TuesdayMar 14, 2017 3:30 pm

VivoPower International PLC (NASDAQ: VVPR) Starts Presentation at 29th Annual Roth Conference

VivoPower International (NASDAQ: VVPR) builds, finances and operates solar power assets. It offers renewable energy for commercial, industrial and government customers. VivoPower was incorporated in 2016 and is based in London, United Kingdom with additional offices in London, United Kingdom; New York, New York; San Francisco, California; Brisbane and North Sydney, Australia; Singapore; Dallas, Texas; and Manila, Philippines. VivoPower International PLC operates as a subsidiary of Arowana International Limited. For more information, visit the company’s website at www.vivopower.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…

TuesdayMar 14, 2017 3:30 pm

PAR Technology Corp. (NYSE: PAR) Starts Presentation at 29th Annual Roth Conference

PAR Technology (NYSE: PAR) provides technology solutions to businesses and organizations in the hospitality industry worldwide. The company’s Hospitality segment offers hardware, software, and a range of support services, including point-of-sale (POS) terminals, tablets, kitchen systems utilizing printers and/or video monitors, and various food safety monitoring and task management hardware and software solutions; and front-of-store POS software applications, operations management software applications, and enterprise software applications for content management and business intelligence. This segment serves restaurants, grocery stores, and specialty retail outlets. The Government segment offers intelligence, surveillance, and reconnaissance; systems engineering and evaluation; satellite and telecommunications; satellite operation, management,…

TuesdayMar 14, 2017 3:30 pm

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Starts Presentation at 29th Annual Roth Conference

Tonix Pharmaceuticals (NASDAQ: TNXP) is a clinical-stage pharmaceutical company that develops medicines for common disorders of the central nervous system. The company’s lead program focuses on post-traumatic stress disorder (PTSD) that is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet, a phase III clinical stage for the treatment of PTSD; and phase II clinical stage for the treatment of military-related PTSD. The company also develops TNX-301, a fixed dose combination drug product that contains disulfiram and selegiline for the treatment of…

TuesdayMar 14, 2017 3:30 pm

Compass Diversified Holdings LLC (NYSE: CODI) Starts Presentation at 29th Annual ROTH Conference

Compass Diversified Holdings (NYSE: CODI) is a private equity firm specializing in acquisitions, buyouts, and middle market investments in North America. The company maintains controlling ownership interests in each of its subsidiaries in order to maximize its ability to impact long term cash flow generation and value. Compass provides both debt and equity capital for its subsidiaries, contributing to their financial and operating flexibility and utilizes the cash flows generated by its subsidiaries to invest in the long-term growth of the company and to make cash distributions to its shareholders. For more information, visit the company’s website www.compassdiversifiedholdings.com. About NetworkNewsWire…

TuesdayMar 14, 2017 3:30 pm

Tower Semiconductor Ltd. (NASDAQ: TSEM) Starts Presentation at 29th Annual Roth Conference

Tower Semiconductor (NASDAQ: TSEM) is an independent semiconductor foundry that manufactures analog intensive mixed-signal semiconductor devices in the United States, Asia and Europe. The company provides various customizable process technologies, including SiGe, BiCMOS, mixed-signal/CMOS, radio frequency CMOS, CMOS image sensor, integrated power management, and micro-electro-mechanical systems. It also offers transfer optimization and development process services to integrated device manufacturers and fabless companies. The company serves various markets, such as consumer, automotive, medical, industrial and aerospace and defense. Tower Semiconductor Ltd. was founded in 1993 and is headquartered in Migdal Haemek, Israel. For more information, visit the company’s website at www.towersemi.com.…

TuesdayMar 14, 2017 3:30 pm

TG Therapeutics, Inc. (NASDAQ: TGTX) Starts Presentation at 29th Annual Roth Conference

TG Therapeutics (NASDAQ: TGTX) is a biopharmaceutical company that focuses on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. The company develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets an epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. For more information, visit the company’s website at www.tgtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…

TuesdayMar 14, 2017 3:30 pm

Auris Medical Holding AG (NASDAQ: EARS) Starts Presentation at 29th Annual ROTH Conference

Auris Medical (NASDAQ: EARS) is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology. The company is focused on the phase 3 development of treatments for acute inner ear hearing loss (AM-111) and for acute inner ear tinnitus (Keyzilen®; AM-101) by way of intratympanic administration with biocompatible gel formulations. In addition, Auris Medical is pursuing intranasal betahistine for Meniere's disease and vestibular vertigo (AM-125) and early-stage research and development projects. The company was founded in 2003 and is headquartered in Zug, Switzerland. For more information, visit the company’s website at www.aurismedical.com. About NetworkNewsWire…

TuesdayMar 14, 2017 3:00 pm

Zafgen, Inc. (NASDAQ: ZFGN) Starts Presentation at 29th Annual Roth Conference

Zafgen (NASDAQ: ZFGN) is a biopharmaceutical company focused on developing therapeutics for patients suffering from obesity and obesity-related disorders. Its lead product candidate is the Beloranib, an injection, which is in phase III clinical trials for the treatment of obesity and hyperphagia in patients with Prader-Willi syndrome; that has completed phase II clinical trials to treat hypothalamic injury-associated obesity, including craniopharyngioma-associated obesity; and which has completed phase IIb clinical trials for the treatment of severe obesity in the general population. The company is also developing ZGN-839, a liver-targeted methionine aminopeptidase 2 (MetAP2) inhibitor that is in pre-clinical studies for the…

TuesdayMar 14, 2017 3:00 pm

Aptose Biosciences, Inc. (NASDAQ: APTO) Starts Presentation at 29th Annual ROTH Conference

Aptose Biosciences (NASDAQ: APTO) is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets on the leading edge of cancer research coupled with companion diagnostics to identify the optimal patient population for its products. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. For more information, visit the company’s website at www.aptose.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: March 2017

Gentherm, Inc. (NASDAQ: THRM) Starts Presentation at 29th Annual ROTH Conference

VivoPower International PLC (NASDAQ: VVPR) Starts Presentation at 29th Annual Roth Conference

PAR Technology Corp. (NYSE: PAR) Starts Presentation at 29th Annual Roth Conference

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Starts Presentation at 29th Annual Roth Conference

Compass Diversified Holdings LLC (NYSE: CODI) Starts Presentation at 29th Annual ROTH Conference

Tower Semiconductor Ltd. (NASDAQ: TSEM) Starts Presentation at 29th Annual Roth Conference

TG Therapeutics, Inc. (NASDAQ: TGTX) Starts Presentation at 29th Annual Roth Conference

Auris Medical Holding AG (NASDAQ: EARS) Starts Presentation at 29th Annual ROTH Conference

Zafgen, Inc. (NASDAQ: ZFGN) Starts Presentation at 29th Annual Roth Conference

Aptose Biosciences, Inc. (NASDAQ: APTO) Starts Presentation at 29th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search